The DOI matches its Crossref record; 198 of the 202 references it cites were found in a registry or an index.
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
Open accessAbstract
Drug repurposing is a strategy consisting of finding new indications for already known marketed drugs used in various clinical settings or highly characterized compounds despite they can be failed drugs. Recently, it emerges as an alternative approach for the rapid identification and development of new pharmaceuticals for various rare and complex diseases for which lack the effective drug treatments. The success rate of drugs repurposing approach accounts for approximately 30% of new FDA approved drugs and vaccines in recent years. This review focuses on the status of drugs repurposing approach for various diseases including skin diseases, infective, inflammatory, cancer, and neurodegenerative diseases. Efforts have been made to provide structural features and mode of actions of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of the main goals of drug repurposing is to shorten the research timeline for discovering new molecules by approximately 50%–60% by utilizing chemically well‐characterized and biologically safe molecules [91].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [91]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 1×
“neurochemical changes in the brain, are the crucial pathological event for AD [137].”
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,718
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Research works printed but not linked: 4
- Gilbert, 2003, Rebuilding big pharma’s business model, in vivo, The Business Med. Rep., 21, 73
- Broughton, 2012, Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study, BMC Gastroenterol., 12, 36, 10.1186/1471-230X-12-36 · DOI
- Regnard, 2011, vol. 42, 319
- Pagan, 2016, vol. 6, 503
Cited by
Sorted by citations
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
“24 Historically, drug repurposing in oncology has largely been driven by either an understanding of the disease pathways or through serendipitous fi ndings.”
BackgroundUtilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 175
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
Begley, C. G., Ashton, M. R., Baell, J. B., Bettess, M. D., Brown, M. P., Carter, B. A., Charman, W. N., Davis, C., Fisher, S., Frazer, I. H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5524 · Cited by 164
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
Parvathaneni, V., & Gupta, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118275 · Cited by 138
Sinha, S. K., Prasad, S. K., Islam, M. A., Gurav, S. S., Patil, R. B., AlFaris, N. A., Aldayel, T. S., AlKehayez, N. M., Wabaidur, S. M., & Shakya, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779132 · Cited by 132
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Müller, L., & Benedetto, S. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 94
Repurposing drugs for the management of COVID-19
Cusinato, J., Cau, Y., Calvani, A. M., & Mori, M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1861248 · Cited by 78
Rodrigues, R. C., Duarte, D., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084280 · Cited by 68
Mousavi, H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.123 · Cited by 65
Maghsoudi, S., Shahraki, B. T., Rameh, F., Nazarabi, M., Fatahi, Y., Akhavan, O., Rabiee, M., Mostafavi, E., Lima, E. C., Saeb, M. R., et al. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14136 · Cited by 64
Pu, J., Yuan, K., Tao, J., Qin, Y., Li, Y., Fu, J., Zhong, L., Zhou, H., Tang, Z., Li, L., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02567-3 · Cited by 71
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
Awadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111330 · Cited by 50
Ozleyen, A., Yılmaz, Y. B., Dönmez, S., Atalay, H. N., Antika, G., & Tumer, T. B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04187-8 · Cited by 48
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
Wu, C., Hsiao, S.-H., & Wu, Y. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101011 · Cited by 47
DrugSpaceX: a large screenable and synthetically tractable database extending drug space
Yang, T., Li, Z. S., Chen, Y., Feng, D., Wang, G., Fu, Z., Ding, X., Tan, X., Zhao, J., Luo, X., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa920 · Cited by 49
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
Pillaiyar, T., Wendt, L. L., Manickam, M., & Easwaran, M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21724 · Cited by 43
Self-citationA drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine
Catalano, R., Rocca, R., Juli, G., Costa, G., Maruca, A., Artese, A., Caracciolo, D., Tagliaferri, P., Alcaro, S., Tassone, P., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111715 · Cited by 38
Liu, W., Wang, G., Wang, Z., Wang, G., Huang, J., & Liu, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.04.003 · Cited by 39
Wang, M., Tang, T., Li, R., Huang, Z., Ling, D., Zheng, L., Ding, Y. P., Liu, T., Xu, W., Zhu, F., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01993 · Cited by 36
Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
García‐Aranda, M., Téllez, T., McKenna, L., & Redondo, M. (2022) · Cancers · doi:10.3390/cancers14092255 · Cited by 36
Drug repositioning for cancer in the era of AI, big omics, and real-world data
Wieder, R., & Adam, N. R. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103730 · Cited by 39
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Girgis, A. S., Panda, S. S., Kariuki, B. M., Bekheit, M. S., Barghash, R. F., & Aboshouk, D. R. (2023) · Molecules · doi:10.3390/molecules28186603 · Cited by 30
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Sadeghi, H. M., Adeli, I., Mousavi, T., Daniali, M., Nikfar, S., & Abdollahi, M. R. (2021) · Life · doi:10.3390/life11080774 · Cited by 29
Pereira, M., Matuszewska, K., Glogova, A., & Petrik, J. (2022) · Cancers · doi:10.3390/cancers14143500 · Cited by 28
Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?
Munafò, A., Burgaletto, C., Benedetto, G. D., Mauro, M. D., Mauro, R. D., Bernardini, R., & Cantarella, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614643 · Cited by 27
PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells
Takeda, T., Yamamoto, Y., Tsubaki, M., Matsuda, T., Kimura, A., Shimo, N., & Nishida, S. (2022) · Oncology Letters · doi:10.3892/ol.2022.13226 · Cited by 29
Druggable targets from coronaviruses for designing new antiviral drugs
Silva, L. R., Santos-Júnior, P. F. D. S., Brandão, J. D. A., Anderson, L., Bassi, Ê. J., de Araújo‐Júnior, J. X., Cardoso, S. H., & da Silva‐Júnior, E. F. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115745 · Cited by 25
Application Progress of Organoids in Colorectal Cancer
Luo, L., Ma, Y., Zheng, Y., Su, J., & Huang, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.815067 · Cited by 30
Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?
Ferreira, S. R., Machado, A. R. T., Furtado, L. F. V., Gomes, J. H. D. S., de Almeida, R. M., Mendes, T. A. D. O., Maciel, V. N., Barbosa, F. S., de Carvalho, L. M., Bueno, L. L., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04402-w · Cited by 23
Sadłocha, M., Toczek, J., Major, K., Staniczek, J., & Stojko, R. (2024) · Pharmaceuticals · doi:10.3390/ph17070827 · Cited by 34
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
Coban, M., Morrison, J. M., Maharjan, S., Hernandez Medina, D. H., Li, W., Zhang, Y. S., Freeman, W. D., Radisky, E. S., Roch, K. G. L., Weisend, C. M., et al. (2021) · eScholarship (California Digital Library) · Cited by 22
Barakat, H. S., Freag, M. S., Gaber, S. M., Oufy, A. A., & Abdallah, O. Y. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s389329 · Cited by 22
Drug Repositioning Using Computer-aided Drug Design (CADD)
Rawat, S., Subramaniam, K., Subramanian, S. K., Saravanan, S., Dhanabalan, S., Chidambaram, S. K. M., Stalin, B., Roy, A., Nagaprasad, N., Aruna, M., et al. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230821103601 · Cited by 22
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
Coban, M. A., Morrison, J. M., Maharjan, S., Medina, D. H. H., Li, W., Zhang, Y. S., Freeman, W. D., Radisky, E. S., Roch, K. G. L., Weisend, C. M., et al. (2021) · Biomolecules · doi:10.3390/biom11060787 · Cited by 27
Drug repurposing strategies and key challenges for COVID-19 management
Mule, S., Singh, A., Greish, K. F., Sahebkar, A., Kesharwani, P., & Shukla, R. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.2013852 · Cited by 22
Hassan, A. H. E., Mahmoud, K., Phan, T.-N., Shaldam, M. A., Lee, C. H., Kim, Y. J., Cho, S. B., Bayoumi, W. A., El‐Sayed, S. M., Choi, Y., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115211 · Cited by 21
Franco, L. S., Maia, R. D. C., & Barreiro, E. J. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00282h · Cited by 21
An Overview on Taxol Production Technology and Its Applications as Anticancer Agent
Sharma, A., Bhatia, S. K., Banyal, A., Chanana, I., Kumar, A., Chand, D., Kulshrestha, S., & Kumar, P. (2022) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-022-0063-3 · Cited by 20
Lamey, C. A., Moussa, N., Helmy, M. W., Haroun, M., & Sabra, S. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104807 · Cited by 20
Krüger, N., Laufer, S., & Pillaiyar, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104364 · Cited by 20
Self-citationSeleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds
Astrain-Redín, N., Talavera, I., Moreno, E., Ramírez, M. J., Martínez‐Sáez, N., Encı́o, I., Sharma, A. K., Sanmartín, C., & Plano, D. (2023) · Antioxidants · doi:10.3390/antiox12010139 · Cited by 18
Sabry, Z., Arora, H. S., Chandrasekaran, S., & Wang, Z. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001340 · Cited by 17
Graves, O. K., Kim, W., Özcan, M., Ashraf, S., Türkez, H., Yuan, M., Zhang, C., Mardinoğlu, A., & Li, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114486 · Cited by 17
Eissa, I. H., Yousef, R. G., Elkady, H., Elkaeed, E. B., Alsfouk, B. A. A., Husein, D. Z., Asmaey, M. A., Ibrahim, I. M., & Metwaly, A. M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154894 · Cited by 17
O’Meara, C. H., Jafri, Z., & Khachigian, L. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411695 · Cited by 18
Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants
Lesmana, M. H. S., Le, N. Q. K., Chiu, W., Chung, K., Wang, C., Irham, L. M., & Chung, M. (2022) · Biomedicines · doi:10.3390/biomedicines10081947 · Cited by 15
Achilonu, C. C., Davies, A. A., Kanu, O. O., Noel, C. B., & Oladele, R. O. (2023) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-023-00269-4 · Cited by 16
Fawzy, M. P., Nafie, M. S., Nabih, N. W., Diab, M. K., Babker, A. M. A., Mohamed, H., Hassan, H. A. F. M., & Fahmy, S. A. (2026) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2026.100168 · Cited by 15
Paudel, K. R., Singh, M., Rubis, G. D., Kumbhar, P., Mehndiratta, S., Kokkinis, S., Sherkawi, T. E., Gupta, G., Singh, S. K., Malik, M. Z., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122859 · Cited by 12
Drug repositioning for Parkinson’s disease: An emphasis on artificial intelligence approaches
Karimi-Sani, I., Sharifi, M., Abolpour, N., Lotfi, M., Atapour, A., Takhshid, M. A., & Sahebkar, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102651 · Cited by 13
Functional diversification and exaptation: the emergence of new drug uses in the pharma industry
Andriani, P., & Cattani, G. (2022) · Industrial and Corporate Change · doi:10.1093/icc/dtac023 · Cited by 13
Utilising Graph Machine Learning within Drug Discovery and DevelopmentPreprint
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R. J., Roberts, C., Tang, J., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2012.05716 · Cited by 11
A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy
Bano, I., Malhi, M., Zhao, M., Giurgiulescu, L., Sajjad, H., & Kieliszek, M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03162-x · Cited by 10
Raj, P., Selvam, K., Roy, K., Tripathi, S. M., Kesharwani, S., Gopal, B., Varshney, U., & Sundriyal, S. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.129008 · Cited by 10
Folliero, V., Dell’Annunziata, F., Santella, B., Roscetto, E., Zannella, C., Capuano, N., Perrella, A., Filippis, A. D., Boccia, G., Catania, M. R., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11092242 · Cited by 11
Hacıosmanoğlu, N., Güngen, M. A., Yilmaz, E. G., Ece, E., Uzun, A., Taşcan, A., Görmüş, B. M., Eş, İ., & İnci, F. (2025) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2025.100588 · Cited by 9
Pathak, S., Parkar, H., Tripathi, S., & Kale, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.591579 · Cited by 9
Mee-udorn, P., Phiwkaow, K., Tinikul, R., Sanachai, K., Maenpuen, S., & Rungrotmongkol, T. (2023) · ACS Omega · doi:10.1021/acsomega.3c01309 · Cited by 9
Mahmoud, A. F., Aboumanei, M. H., Abd‐Allah, W. H., Swidan, M. M., & Sakr, T. M. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2078001 · Cited by 9
Synthesis and Conformational Analysis of Hydantoin-Based Universal Peptidomimetics
Caramiello, A. M., Bellucci, M. C., Cristina, G., Castellano, C., Meneghetti, F., Mori, M., Secundo, F., Viani, F., Sacchetti, A., & Volonterio, A. (2022) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c01903 · Cited by 9
Machine Learning Applications for Drug Repurposing
Yingngam, B. (2024) · doi:10.1002/9781394234196.ch9 · Cited by 9
Zhang, S., Zhang, R., Zheng, L., Liu, Y., Fan, Q., Liu, Y., Ning, X., Zhang, Y., Chen, Y., & Liu, H. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11247-x · Cited by 8
Picarazzi, F., Zuanon, M., Pasqualetto, G., Cammarone, S., Romeo, I., Young, M. T., Brancale, A., Bassetto, M., & Mori, M. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01040 · Cited by 8
Pawar, V. A., Tyagi, A., Verma, C., Sharma, K. P., Ansari, S., Mani, I., Srivastva, S. K., Shukla, P. K., Kumar, A., & Kumar, V. (2023) · PubMed Central · Cited by 8
Lakshmi, S., Shanitha, A., Dv, S., Bs, R., Saikant, R., Sharaf, S., Sa, A., & Rajmohan, G. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100080 · Cited by 8
Pharmacokinetics and pharmacodynamics analysis of drug candidates
Singh, S., Singh, D. B., Gautam, B., Singh, A., & Yadav, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00001-8 · Cited by 7
Current Status on 1,4-Dihydropyridine Derivatives against Human Pathogenic Parasites
Elso, O. G., Liñares, G. G., & Sülsen, V. P. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221104162901 · Cited by 7
Hershan, A. A. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.104023 · Cited by 7
Sahasrabuddhe, A., Oakley, D., Chen, K., & McCarter, J. D. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220979596 · Cited by 7
Rutin increases alpha‐tubulin acetylation via histone deacetylase 6 inhibition
Çetin, Ö., Sarı, S., Erdem‐Yurter, H., & Bora, G. (2022) · Drug Development Research · doi:10.1002/ddr.21927 · Cited by 8
Antona, A., Varalda, M., Roy, K., Favero, F., Mazzucco, E., Zuccalà, M., Leo, G., Soggia, G., Bettio, V., Tosi, M., et al. (2022) · Cancers · doi:10.3390/cancers14030776 · Cited by 8
e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7
“One of the main goals of drug repurposing is to shorten the research timeline for discovering new molecules by approximately 50%–60% by utilizing chemically well-characterized and biologically safe molecules [91].”
Anti-aging and immunomodulatory role of caffeine in Drosophila larvae
Nainu, F., Sartini, S., Bahar, M. A., Asbah, A., Rosa, R. A., Mudjahid, M., As’ad, M. F., & Latada, N. P. (2024) · Narra J · doi:10.52225/narra.v4i2.818 · Cited by 6
Panthi, S., Hong, J.-Y., Satange, R., Yu, C., Li, L., & Hou, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136996 · Cited by 7
The multitarget approach as a green tool in medicinal chemistry
Vlocskó, R. B., Apaydın, S., Török, B., & Török, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822248-5.00016-4 · Cited by 6
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library
Orro, A., Uggeri, M., Rusnati, M., Urbinati, C., Pedemonte, N., Pesce, E., Moscatelli, M., Padoan, R., Cichero, E., Fossa, P., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113186 · Cited by 6
Wang, Z. P., Li, X., Matsumoto, N., Venkatesan, M., Chang, J.-H., Moran, J., Choi, H., Li, B., Meng, Y., Hernandez, M. E., et al. (2025) · BioData Mining · doi:10.1186/s13040-025-00466-5 · Cited by 7
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias
Moya-Garzón, M. D., Gómez-Vidal, J. A., Alejo‐Armijo, A., Altarejos, J., Madoz, J. R. R., Fernandes, M. X., SALIDO, E. C., Salido, S., & Díaz‐Gavilán, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020074 · Cited by 5
CADD Approaches in Anticancer Drug Discovery
Biswas, A., & Jayaprakash, V. (2023) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-99-1316-9_12 · Cited by 5
Su, M., Lee, A. M., Zhang, W., Maeser, D., Gruener, R. F., Deng, Y., & Huang, R. S. (2024) · Pharmaceuticals · doi:10.3390/ph17050569 · Cited by 5
Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat modelPreprint
Centeno, M. V., Alam†, M. S., Haldar, K., & Apkarian, A. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.13.571583 · Cited by 5
Advances in the approaches used to repurpose drugs for neuroblastoma
Miera-Maluenda, M., Pérez-Torres, M., Mañas, A., Rubio‐San‐Simón, A., Butjosa-Espín, M., Ruiz-Duran, P., Seoane, J. A., Moreno, L., & Segura, M. F. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2402413 · Cited by 4
Centeno, M. V., Alam†, M. S., Haldar, K., & Apkarian, A. V. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105396 · Cited by 8
Rahman, M. M., Islam, M. R., Tumpa, M. A. A., Shohag, S., shuvo, S. K., Ferdous, J., Kajol, S. A., Aljohani, A. S. M., Abdulmonem, W. A., Rauf, A., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110375 · Cited by 4
A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures
Mokou, M., Narayanasamy, S., Stroggilos, R., Balaur, I., Vlahou, A., Mischak, H., & Frantzi, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3291-8_4 · Cited by 4
Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials
Abdalla, E. H. E., Alenezi, B. T., Soliman, M. M., Jan, M., & Soliman, A. (2025) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.295 · Cited by 3
Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation**
Wang, Q.-X., Cai, J., Chen, Z., Liu, J., Wang, J., Zhou, H., Li, Q., Wang, Z., Wang, Y., Tong, Z., et al. (2024) · Molecular Informatics · doi:10.1002/minf.202300336 · Cited by 3
Synthesis of New Bi-Triazoles with Plasmocide Action Against Plasmodium falciparum
Addla, D., Diniz, C. S., de Santana, Q. L. O., Martinez, L. D. N., Almeida, M. L., da Silva, M. A., do Nascimento, W. D. S. P., Gouveia, A. D. J., Fialho, S. N., Ferreira, A. D. S., et al. (2022) · Current Bioactive Compounds · doi:10.2174/1573407219666221117113556 · Cited by 3
de Jesus, I. S., de Pontes, J. B., de Carvalho, A. S., Ferreira, P. G., de Souza, A. S., da Silva, F. D. C., Paschoalin, V. M. F., Futuro, D. O., & Ferreira, V. F. (2025) · Current Organic Chemistry · doi:10.2174/0113852728332274241104114316 · Cited by 3
Sano, N., Yoshino, H., Sato, Y., HONMA, H., Cordonier, C. E. J., & Kashiwakura, I. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230407094658 · Cited by 3
Gavandi, T. C., Patil, S. B., Basrani, S. T., Yankanchi, S. R., Chougule, S. A., Karuppayil, S. M., & Jadhav, A. K. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01344-8 · Cited by 2
Harnessing antimalarial chemical space: the way forward
Sundriyal, S., & Majumdar, A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2582539 · Cited by 2
Vukadinović, D., Damjanović, A., Vukovic, M., Cudina, O. A., Grahovac, J., & Dobričić, V. (2025) · Molecules · doi:10.3390/molecules31010125 · Cited by 2
Dove, A. S., Abdelsattar, A. S., Abutaleb, N. S., & Seleem, M. N. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01231-25 · Cited by 2
Mohanapriya, D., & Beena, R. (2020) · European Journal of Molecular & Clinical Medicine · Cited by 2
Fossa, P., Uggeri, M., Orro, A., Urbinati, C., Rondina, A., Milanesi, M., Pedemonte, N., Pesce, E., Padoan, R., Ford, R. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012274 · Cited by 2
Liang, X., Li, C., Yuan, W., Ji, M., Zhang, J., Yan, M., Lu, Q., Gou, J., Yin, T., He, H., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123800 · Cited by 2
Drug and formulation development processes
Charoo, N. A., Mohamed, E. M., Eltigani, M., Khan, M. A., Nutan, M. T. H., & Rahman, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91111-5.00007-x · Cited by 2
Computational Approaches for Structure-Assisted Drug Discovery and Repurposing
Pandey, A. K., & Verma, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7123-3_9 · Cited by 3
Metadata
- Authors
- Pillaiyar, T., Meenakshisundaram, S., Manickam, M., & Sankaranarayanan, M.
- Affiliations
- University of Bonn (DE)
- PSG INSTITUTE OF TECHNOLOGY AND APPLIED RESEARCH (IN)
- Corresponding author
- Pillaiyar, Thanigaimalai
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 195
- Pages
- 112275
- ISSN
- 0223-5234 (ISSN-L)
- PMC
- PMC7156148
- OpenAlex
- W3013498471
- Cited by
- 140
- References
- 202
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 18 · 2023: 25 · 2022: 26 · 2021: 15 · 2020: 17
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Medicinal Chemistry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- PSG
- PSG Institute of Technology and Applied Research
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- drug repurposing, marketed drugs, rare diseases, skin diseases, infectious diseases, inflammatory diseases, cancer, neurodegenerative diseases, structural features, mechanism of action
- MeSH terms
- Animals, Chemistry, Pharmaceutical, Humans, Drug Discovery, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
